
A visionary entrepreneur and 3x founder, with a strong track record of building transformative companies. He leads with a focus on innovation, pioneering advanced solutions that reshape healthcare, and drive impactful change across the industry.

AI/ML pioneer with deep expertise in medical imaging and platform engineering. Leads technical development of Nucs AI’s core technologies, ensuring clinical accuracy and scalability.

A biomedical engineer turned strategist and operations leader, with a track record of driving growth and market expansion across startups and established life-science companies. Works across all teams to scale Nucs AI and accelerate access to AI-driven precision imaging solutions.

Clinical imaging expert with extensive experience across oncology, musculoskeletal, neuroradiology, and women’s health. Brings deep clinical insight and leadership to guide development and integration of Nucs AI’s precision imaging solutions, ensuring accuracy, quality, and impact in patient care.

A product builder and operations leader, with experience spanning early-stage startups to multinational companies. Skilled in strategic planning, analysis, policy creation, sales, and recruiting, with a focus on solving operational challenges and scaling resilient teams. Dedicated to understanding customer needs and driving sustainable growth through pragmatic execution.
Our medical advisors are global leaders in nuclear medicine and theranostics, shaping how prostate cancer is diagnosed and treated through cutting-edge research, clinical insight, and a commitment to patient-centered innovation.

Director of Theranostics and Clinical Research, UCLA. International expert in nuclear medicine and cancer imaging. Leads clinical trials and scientific strategy for PSMA-targeted diagnostics and therapies. Author of 200+ publications and Associate Editor of The Journal of Nuclear Medicine.

Director of Nuclear Medicine and Theranostics, IEO Milan. International expert in molecular imaging and radioligand therapy. Leads clinical research and innovation in PSMA-targeted theranostics. Associate Professor at the University of Milan and recognized leader in precision cancer care.
Our team brings together experts in nuclear medicine, machine learning, oncology, and health systems design — united by a shared goal: improving outcomes in prostate cancer through better tools, better data, and better care.





